Merck KGaA - ROE
MRK.DE
Price:
$137.85
Market Cap:
$59.89B
Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and various industrial sectors. It also offers specialized process development expertise, such as continuous bioprocessing for drug manufacturers, provides a range of testing kits, reagents, and services, and develops solutions for analyzing environmental samples like air, water, and soil. Furthermore, this segment aids in assessing nutritional value and identifying quality control issue...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1998-06-26
Stock Exchange
XETRA
Ticker
MRK.DE
PE Ratio
[16.41]
ROE
[8.08%]
Current Ratio
[1.69]
Dividend Yield
[1.60%]
Enterprise Value
[70.24B]
Dividend History
The ROE as of October 2026 (TTM) for Merck KGaA (MRK.DE) is 8.08%
According to Merck KGaA’s latest financial reports and current stock price. The company's current ROE is 8.08%. This represents a change of 299.97% compared to the average of 2.02% of the last 4 quarters.
Merck KGaA (MRK.DE) Historical ROE (quarterly & annually)
How has MRK.DE ROE performed in the past?
The mean historical ROE of Merck KGaA over the last ten years is 11.21%. The current 8.08% ROE has changed -27.94% with respect to the historical average. Over the past ten years (40 quarters), MRK.DE's ROE was at its highest in in the December 2017 quarter at 7.23%. The ROE was at its lowest in in the March 2019 quarter at 1.07%.
Average
11.21%
Median
11.11%
Minimum
6.57%
Maximum
18.60%
Merck KGaA (MRK.DE) ROE by Quarter and Year
Discovering the peaks and valleys of Merck KGaA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 59.75%
Maximum Annual ROE = 18.60%
Minimum Annual Increase = -64.68%
Minimum Annual ROE = 6.57%
| Year | ROE | Change |
|---|---|---|
| 2025 | 9.12% | -1.75% |
| 2024 | 9.28% | -12.29% |
| 2023 | 10.58% | -17.46% |
| 2022 | 12.82% | -10.43% |
| 2021 | 14.32% | 22.10% |
| 2020 | 11.73% | 58.69% |
| 2019 | 7.39% | 12.47% |
| 2018 | 6.57% | -64.68% |
| 2017 | 18.60% | 59.75% |
| 2016 | 11.64% | 33.57% |
Merck KGaA (MRK.DE) Average ROE
How has MRK.DE ROE performed in the past?
The current ROE of Merck KGaA (MRK.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.66%
5-year avg
11.23%
10-year avg
11.21%
Merck KGaA (MRK.DE) ROE vs. Peers
How is MRK.DE’s ROE compared to its peers?
Merck KGaA’s ROE is greater than Bayer Aktiengesellschaft (-6.10%), less than Merck & Co., Inc. (6.60%), less than GSK plc (28.35%), less than Teva Pharmaceutical Industries Limited (9.18%), less than Galderma Group AG (10.46%), less than Jiangsu Hengrui Medicine Co., Ltd. (12.42%), less than Sun Pharmaceutical Industries Limited (14.96%), less than Haleon plc (9.89%), less than Sandoz Group AG (7.04%),
| Company | ROE | Market cap |
|---|---|---|
| -6.10% | $43.00B | |
| 6.60% | $319.55B | |
| 28.35% | N/A | |
| 9.18% | $139.76B | |
| 10.46% | $38.46B | |
| 12.42% | $298.86B | |
| 14.96% | $4.22T | |
| 9.89% | N/A | |
| 7.04% | $30.17B |
Build a custom stock screener for Merck KGaA (MRK.DE) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Merck KGaA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Merck KGaA (MRK.DE) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Merck KGaA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Merck KGaA's ROE?
How is the ROE calculated for Merck KGaA (MRK.DE)?
What is the highest ROE for Merck KGaA (MRK.DE)?
What is the 3-year average ROE for Merck KGaA (MRK.DE)?
What is the 5-year average ROE for Merck KGaA (MRK.DE)?
How does the current ROE for Merck KGaA (MRK.DE) compare to its historical average?